(Q42934914)

English

In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B--a clue for vaccine development

scientific article published on 15 August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 November 2017

In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B--a clue for vaccine development (English)

1 reference

Europe PubMed Central

11 November 2017

Neisseria meningitidis

1 reference

based on heuristic

inferred from title

author name string

Shishir K Gupta

1

1 reference

Europe PubMed Central

11 November 2017

Suchi Smita

2

1 reference

Europe PubMed Central

11 November 2017

Aditya Narayan Sarangi

3

1 reference

Europe PubMed Central

11 November 2017

Mugdha Srivastava

4

1 reference

Europe PubMed Central

11 November 2017

Bashir A Akhoon

5

1 reference

Europe PubMed Central

11 November 2017

Qamar Rahman

6

1 reference

Europe PubMed Central

11 November 2017

Shailendra K Gupta

7

1 reference

Europe PubMed Central

11 November 2017

language of work or name

0 references

publication date

15 August 2010

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

28

1 reference

Europe PubMed Central

11 November 2017

43

1 reference

Europe PubMed Central

11 November 2017

7092-7097

1 reference

Europe PubMed Central

11 November 2017

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

based on heuristic

inferred from DOI database lookup

Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Vaccines for prevention of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

The immunopathogenesis of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Immunologic response of man to group B meningococcal polysaccharide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in Man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Alternative vaccine strategies to prevent serogroup B meningococcal diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Meningococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Auto-transporter A protein of Neisseria meningitidis: a potent CD4+ T-cell and B-cell stimulating antigen detected by expression cloning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Neisserial immunoglobulin A1 protease induces specific T-cell responses in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Novel vaccine strategies to T-independent antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Evidence for dendritic cell-dependent CD4(+) T helper-1 type responses to commensal bacteria in normal human intestinal lamina propria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Bacterial meningitis: T cell activation and immunoregulatory CD4+ T cell subset alteration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Murine cross-reactive T-cell epitopes of Neisseria meningitidis outer membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Predicting population coverage of T-cell epitope-based diagnostics and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Genetic affinities of north and northeastern populations of India: inference from HLA-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

MHCBN 4.0: A database of MHC/TAP binding peptides and T-cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

The immune epitope database 2.0.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

SYFPEITHI: database for MHC ligands and peptide motifs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Immunomics: discovering new targets for vaccines and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Information technologies for vaccine research

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

In silico DNA vaccine designing against human papillomavirus (HPV) causing cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Memory T cells and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

MHC superfamily structure and the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Antigenic peptide binding by class I and class II histocompatibility proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

The changing field of vaccine development in the genomics era

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Variation in vaccine response in normal populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Viral peptide immunogens: current challenges and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Immuno-informatics: Mining genomes for vaccine components

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Towards in silico prediction of immunogenic epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Quantitative structure-activity relationships and the prediction of MHC supermotifs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Harnessing bioinformatics to discover new vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

The societal value of universal childhood vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Developing an epitope-driven tuberculosis (TB) vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Predicted epitopes of Lig A of Leptospira interrogans by bioinformatics method: a clue for further vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

Identification and characterization of TspA, a major CD4(+) T-cell- and B-cell-stimulating Neisseria-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.005

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.08.005

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42934914&oldid=1974048876"